Trading on Friday took place in a narrow range, from $5.66 to $5.75. Working back from the reported close and percentage change, the implied prior close is roughly $6.96, meaning the entire day's trading took place well below the previous session's close.
Clinical-stage biotech names like Candel are inherently binary and sentiment-driven. Their value rests on expectations about programs still working their way through development and toward regulatory milestones, and the company is advancing toward a year-end biologics license application filing for a prostate cancer therapy. …
The contrast with the rest of the group was stark. Technology was the single biggest weight on the market, with the sector falling roughly 2% in a second consecutive daily decline. The epicenter was Nvidia (NASDAQ:NVDA), which extended its slide to fresh 52-week lows …
Baidu, Inc. filed its unaudited third-quarter 2026 financial results on November 16, 2026, reporting total revenue of RMB30.8 billion and a 94% year-over-year surge in AI Cloud Infra revenue.
Key HighlightsConsumer Staples Lead Sector Gains:XLP advanced 1.42%, recording the strongest performance among the eleven supplied sector ETFs, supported by gains in Coca-Cola, PepsiCo and Walmart.Communication Services and Energy Advance:XLC gained 1.05%, while XLE increased 0.98%, reflecting strength in selected large-cap communication companies and …
Key HighlightsSix Sectors Occupy Leading:Industrials (XLI), Financials (XLF), Consumer Discretionary (XLY), Real Estate (XLRE), Health Care (XLV) and Utilities (XLU) are positioned in the Leading quadrant, indicating positive relative strength and momentum.Utilities Enters Leading:XLU has moved into the Leading quadrant, reflecting an improvement in …
Among the top-performing stocks of the session Focus Universal Inc. surged 136.00%, while VirTra, Inc. rallied 61.83%. On the losing side, Suncrete, Inc. fell 37.44%, while Neuropace, Inc. declined 37.10%, making them the weakest performers during the trading day.
Evotec SE announced on November 16, 2026 that it has been awarded a $2.9 million grant from the Gates Foundation to extend its human stem cell-based fetal developmental safety screening program for a further three years.
FF EAI Robotics Ecosystem Inc. filed a weekly business update on November 15, 2026, disclosing robot deliveries, first financial results since completing its robotics acquisition, and 2026 full-year guidance reaffirmation.
CVS Health (NYSE:CVS) had a good quarter and a bad day. On November 4th it reported adjustedEarningsof $2.09 a share, against the $1.65 analysts expected. It raised its 2026 forecast to at least $8.20 and guided to at least $8.65 for 2027, ahead of …